Certican 0.25mg Tablet
Prescription Required
Product introduction
Certican 0.25mg Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body’s immune response, so the body can accept the new organ. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Certican 0.25mg Tablet is used to prevent the body rejecting the organ that is transplanted and also to prevent cancer post organ transplant
Certican 0.25mg Tablet is used to prevent the body rejecting the organ that is transplanted and also to prevent cancer post organ transplant
Uses of Certican Tablet
Benefits of Certican Tablet
In Prevention of organ rejection in transplant patients
Certican 0.25mg Tablet is used with other medications to prevent organ transplant rejection. Rejection usually happens due to attack by the immune system of the person receiving the transplanted organ on the transplant itself, in people who are receiving any organ transplants, like kidney, liver, heart etc. This medicine reduces the activity of a person's own immune system and prevents any such rejection.
In Treatment of Breast cancer
Certican 0.25mg Tablet is used to treat breast cancer in postmenopausal women when other medicines have failed to show significant improvement. It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. Take is as advised to get maximum relief.
In Treatment of Pancreatic cancer
Pancreas are very essential for digestion of whatever you eat and also for metabolism of blood sugar levels as they produce the body’s natural insulin. This medicine will help to control pancreatic cancer, and will relieve the symptoms such as, lack of appetite or unexplained weight loss. Certican 0.25mg Tablet helps to stop the action of those chemicals that aid in pancreatic cancer growth and spread. It will help you live a longer and healthier life.
In Treatment of Lung cancer
Certican 0.25mg Tablet reduces the blood supply to the cancer cells and stops its growth. But, as it reduces the immunity, avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to. Take a healthy diet and keep taking the medicine as prescribed to get the full benefits.
In Treatment of Kidney cancer
Certican 0.25mg Tablet is used to treat kidney cancer when other medicines have failed to work. It stops cancer growth and prevents multiplication of cancer cells. This restricts the advancement of cancer to other unaffected regions. You need to follow your doctor’s instructions very carefully to recover. Take it as prescribed to get the maximum benefit.
Side effects of Certican Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Certican
- Weakness
- Sinus inflammation
- Infection
- Fever
- Cough
- Fatigue
- Stomatitis (Inflammation of the mouth)
- Otitis media (infection of ear)
- Diarrhea
- Upper respiratory tract infection
How to use Certican Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Certican 0.25mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Certican 0.25mg Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Certican 0.25mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Certican 0.25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Certican 0.25mg Tablet may cause side effects which could affect your ability to drive.
As fatigue is a common side effect with Certican 0.25mg Tablet and this may affect your ability to drive
As fatigue is a common side effect with Certican 0.25mg Tablet and this may affect your ability to drive
Kidney
SAFE IF PRESCRIBED
Certican 0.25mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Certican 0.25mg Tablet is recommended.
Liver
CAUTION
Certican 0.25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Certican 0.25mg Tablet may be needed. Please consult your doctor.
Use of Certican 0.25mg Tablet is not recommended in patients with severe liver disease.
Use of Certican 0.25mg Tablet is not recommended in patients with severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Certican 0.25mg Tablet
₹78.9/Tablet
Advacan 0.25mg Tablet
Biocon
₹48.35/tablet
39% cheaper
Evergraf 0.25mg Tablet
Panacea Biotec Ltd
₹57.9/tablet
27% cheaper
Lanolimus 0.25mg Tablet
Mylan Pharmaceuticals Pvt Ltd
₹40.6/tablet
49% cheaper
Suregraft 0.25 Tablet
Hospimax Healthcare Pvt Ltd
₹44.8/tablet
43% cheaper
Everomus 0.25mg Tablet
Zydus Cadila
₹75/tablet
5% cheaper
Quick tips
- Certican 0.25mg Tablet is given for the treatment of certain cancers and to prevent organ transplant rejection.
- Certican 0.25mg Tablet may affect male or female fertility; consult your doctor if you are planning to have a child.
- Inform your doctor straight away if you think you are getting a sore throat or if you have a high temperature. This is because Certican 0.25mg Tablet increases your risk of getting an infection.
- While you are taking Certican 0.25mg Tablet do not take any vaccinations without talking to your doctor first.
- If you are having an operation or dental treatment, always tell the person carrying out the treatment that you are taking Certican 0.25mg Tablet.
- Do not drink grapefruit juice while you are taking this medicine. This is because a chemical in grapefruit juice can interfere with the action of Certican 0.25mg Tablet.
Fact Box
Chemical Class
Macrolide Lactams
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Immunosuppressant- mTOR inhibitors
Patient concerns
User feedback
Patients taking Certican 0.25mg Tablet
Twice A Day
82%
Once A Day
17%
Thrice A Day
1%
What are you using Certican Tablet for?
Kidney cancer
67%
Others
33%
How much was the improvement?
Poor
67%
Average
33%
Please rate Certican 0.25mg Tablet on price
Not Expensive
67%
Average
33%
FAQs
Is any monitoring required while taking Certican 0.25mg Tablet?
Regular monitoring is required while you are on Certican 0.25mg Tablet. The doctor will advise blood tests to see the counts of red blood cells, white blood cells, and platelets since the counts may decrease during treatment with Certican 0.25mg Tablet. Also, blood tests will be required to check your kidney function, liver function, blood glucose levels, and cholesterol levels.
What should I avoid while taking Certican 0.25mg Tablet?
You should avoid grapefruit or grapefruit juice while taking Certican 0.25mg Tablet. This is because taking them together may increase the levels of Certican 0.25mg Tablet in your blood to harmful levels. Avoid the use of live vaccinations and any possible contact with individuals who have received live vaccinations.
What is the most important information I need to know about Certican 0.25mg Tablet?
Certican 0.25mg Tablet can cause serious side effects which include severe allergic reactions, angioedema, and kidney failure which can be severe and can lead to death. It is possible that you may develop an infection or problems related to lung such as breathing problems.
Is Certican 0.25mg Tablet a chemotherapy?
Certican 0.25mg Tablet is an anticancer medicine. It belongs to kinase inhibitor class of medicines. It works by reducing the blood supply to the tumor, which slows down the growth and spread of cancer cells.
How is Certican 0.25mg Tablet administered?
Usually, Certican 0.25mg Tablet is taken once or twice daily. The medicine should always either be taken with food or always be taken without food. Certican 0.25mg Tablet should be swallowed whole with water and should not be crushed or chewed.
How long can you take Certican 0.25mg Tablet?
There is no definite duration of treatment with Certican 0.25mg Tablet. Certican 0.25mg Tablet is continued till clinical benefit is seen or unacceptable toxicity or side effects occur.
How will I know that Certican 0.25mg Tablet is shrinking my brain tumor?
The effect of Certican 0.25mg Tablet in shrinking the size of tumor can only be checked by getting regular brain scans. It should be done as advised by your doctor and your treatment plan.
Is Certican 0.25mg Tablet cytotoxic?
Yes, Certican 0.25mg Tablet is cytotoxic against human cancer cells of breast, stomach, prostate, and kidneys (renal cell carcinoma).
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Krensky AM, Bennett WM, Vincenti F. Immunosuppressants, Tolerogens, and Immunostimulants. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1013.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 526.
- Everolimus. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2009 [revised Apr. 2018]. [Accessed 06 Apr. 2019] (online) Available from:
- Everolimus. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2011 [revised 12 Jul 2018]. [Accessed 22 Jan. 2019] (online) Available from:
Marketer details
Name: Novartis India Ltd
Address: Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
Country of origin: Switzerland
Lab tests offered by us
Related/Popular tests
44 people bought this recentlyMRP
₹789
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT